Gorham's disease: an osseous disease of lymphangiogenesis?

Kavita Radhakrishnan1, Stanley G Rockson

  • 1Stanford Center for Lymphatic and Venous Disorders, Division of Cardiovascular Medicine, Stanford University School of Medicine, 300 Pasteur Drive, Stanford, CA 94305, USA.

Insights

Gorham's disease, a rare bone disorder, involves bone loss and abnormal lymphatic vessel growth. Understanding its lymphangiogenesis pathways is key for future treatment strategies.

Area of Science:

  • Musculoskeletal system disorders
  • Vascular biology
  • Rare diseases

Background:

  • Gorham's disease (GD), or massive osteolysis, is a rare musculoskeletal condition.
  • It presents with osteolysis and proliferation of lymphatic channels, often leading to chylous ascites.
  • Current understanding of GD's molecular mechanisms and standardized treatments is limited.

Purpose of the Study:

  • To highlight the critical role of disordered lymphangiogenesis in Gorham's disease.
  • To explore potential therapeutic targets by connecting GD to recent lymphatic research.
  • To provide a foundation for future research into Gorham's disease.

Main Methods:

  • Review of existing literature on Gorham's disease.
  • Analysis of the relationship between osteolysis and lymphatic system abnormalities.
  • Integration of recent findings in lymphangiogenesis research.

Main Results:

  • Gorham's disease is characterized by bone destruction and abnormal lymphatic vessel proliferation.
  • Leaky lymphatic vessels contribute to systemic complications like chylous ascites.
  • Several lymphangiogenic pathways are implicated in the disease process.

Conclusions:

  • Gorham's disease is fundamentally a disorder of abnormal lymphangiogenesis.
  • Future research should focus on understanding and targeting these lymphangiogenic pathways.
  • Identifying these pathways may lead to novel treatment strategies for Gorham's disease.

Related Concept Videos

Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Secondary Lymphoid Organs01:15

Secondary Lymphoid Organs

Secondary organs, including lymph nodes, the spleen, and mucosa-associated lymphoid tissue (MALT), work harmoniously to protect us from disease and infection.
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
Goiter01:27

Goiter

Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
Development of the Lymphatic System01:15

Development of the Lymphatic System

The development of lymphatic tissues and vessels in embryonic life begins around the fifth week. These structures originate from the mesoderm layer, with lymph sacs emerging from developing veins.
The first lymph sacs to form are the paired jugular lymph sacs located at the junction of the internal jugular and subclavian veins. From these sacs, lymphatic capillary plexuses extend to the thorax, upper limbs, neck, and head, eventually forming lymphatic vessels. Each jugular lymph sac maintains a...
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...